High-density lipoprotein, sphingosine 1-phosphate, and atherosclerosis

Journal of Clinical Lipidology

Volumn 2, Issue 1, 2008, Pages 4-11

  Nofer, Jerzy Roch ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Atherosclerosis; High density lipoprotein; Lysosphingolipids; Myocardial infarction; Sphingosine 1 phosphate

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROSTACYCLIN; PROTEIN KINASE B; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SPHINGOSINE 1 PHOSPHATE; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL INTERACTION; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; LIPID TRANSPORT; LYMPHOCYTE; MACROPHAGE; MEDICAL RESEARCH; MEDLINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 39149137805     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2007.11.002     Document Type: Review

References (84)

1. Assmann G., and Nofer J.-R. The protective role of HDL. In: Carlson L.A. (Ed). Lectures in Clinical Atherosclerosis and Dyslipidemia. Part 3 (2005), Science Press, Current Medical Group, London
2. Ridker P.M. High sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103 (2001) 1813-1818
3. Nofer J.R., Walter M., and Assmann G. Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence. Exp Rev Cardiovasc Ther 3 (2005) 1071-1086
4. Anliker B., and Chun J. Lysophospholipid G protein-coupled receptors. J Biol Chem 279 (2004) 20555-20558
5. Murata N., Sato K., Kon J., et al. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 3 (2000) 809-815
6. 3. J Clin Invest 113 (2004) 569-581
7. Tamama K., and Okajima F. Sphingosine 1-phosphate signaling in atherosclerosis and vascular biology. Curr Opin Lipidol 13 (2002) 489-495
8. Zhang B., Tomura H., Kuwabara A., et al. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins. Atherosclerosis 178 (2005) 199-205
9. Taha T.A., Hannun Y.A., and Obeid L.M. Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol 39 (2006) 113-131
10. Venkataraman K., Thangada S., Michaud J., et al. Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem J 397 (2006) 461-471
11. Clair T., Aoki J., Koh E., et al. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res 63 (2003) 5446-5453
12. Spiegel S., and Milstein S. Sphingosine 1-phosphate: an enigmatic signaling lipid. Nat Rev Moll Cell Biol 4 (2003) 397-407
13. Yatomi Y., Ruan F., Hakomori S., and Igarashi Y. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86 (1995) 193-202
14. Ito K., Anada Y., Tani M., et al. Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. Biochem Biophys Res Commun 357 (2007) 212-217
15. Yatomi Y., Ohmori T., Rile G., et al. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood 96 (2000) 3431-3438
16. Hänel P., Andréani P., and Gräler M.H. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 21 (2007) 1202-1209
17. Mitra P., Oskeritzian C.A., Payne S.G., Beaven M.A., Milstien S., and Spiegel S. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci U S A 103 (2006) 16394-16399
18. Graeler M., Shankar G., and Goetzl E.J. Cutting edge: suppression of T cell chemotaxis by sphingosine 1-phosphate. J Immunol 169 (2002) 4084-4087
19. Graeler M., and Goetzl E.J. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J 16 (2002) 1874-1878
20. Wang W., Graeler M., and Goetzl E.J. Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration. FASEB J 19 (2005) 1731-1733
21. Wang W., Graeler M., and Goetzl E.J. Physiological sphingosine 1-phosphate requirement for optimal activity of mouse CD4+ regulatory T cells. FASEB J 18 (2004) 1043-1045
22. Ait-Oufella H., Salomon B.L., Potteaux S., et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12 (2006) 178-180
23. Mandala S., Hajdu R., Bergstrom J., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296 (2002) 346-349
24. Honig S.M., Fu S., Mao X., et al. TY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. J Clin Invest 111 (2003) 627-637
25. Allende M.L., Dreier J.L., Mandala S., and Proia R.L. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem 279 (2004) 15396-15401
26. Wei S.H., Rosen H., Matheu M.P., et al. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol 6 (2005) 1228-1235
27. Hamada K., Nakamura H., Oda T., Hirano T., Shimizu N., and Utiyama H. Involvement of Mac-1-mediated adherence and sphingosine 1-phosphate in survival of phorbol ester-treated U937 cells. Biochem Biophys Res Commun 244 (1998) 745-750
28. Gomez-Munoz A., Kong J., Salh B., and Steinbrecher U.P. Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. FEBS Lett 539 (2003) 56-60
29. Weigert A., Johann A.M., von Knethen A., Schmidt H., Geisslinger G., and Brune B. Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. Blood 108 (2006) 1635-1642
30. Garcia J.G., Liu F., Verin A.D., et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 108 (2001) 689-701
31. Schaphorst K.L., Chiang E., Jacobs K.N., et al. Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am J Physiol Lung Cell Mol Physiol 285 (2003) L258-L267
32. Lindner K., Uhlig U., and Uhlig S. Ceramide alters endothelial cell permeability by a nonapoptotic mechanism. Br J Pharmacol 145 (2005) 132-140
33. Birukov K.G., Birukova A.A., Dudek S.M., et al. Shear stress-mediated cytoskeletal remodeling and cortactin translocation in pulmonary endothelial cells. Am J Respir Cell Mol Biol 26 (2002) 453-464
34. Dudek S.M., Peng X., Birukov K.G., et al. Mechanisms of sphingosine 1-phosphate mediated lung vascular barrier enhancement in vivo and in vitro. J Biol Chem 279 (2004) 24692-24700
35. Shikata Y., Birukov K.G., and Garcia J.G.N. Site-specific FAK phosphorylation is involved in sphingosine 1-phosphate- and thrombin-induced focal adhesion remodeling: role of src, GIT1 and GIT2. FASEB J 17 (2003) 2240-2249
36. Lee J.F., Zeng Q., Ozaki H., et al. Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity. J Biol Chem 281 (2006) 29190-29200
37. Feistritzer C., and Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105 (2005) 3178-3184
38. Singleton P.A., Dudek S.M., Ma S.F., and Garcia J.G. Transactivation of sphingosine-1-phosphate receptors is essential for vascular barrier regulation: novel role for hyaluronan and CD44 receptor family. J Biol Chem 281 (2006) 34381-34393
39. Hisano N., Yatomi Y., Satoh K., et al. Induction and suppression of endothelial cell apoptosis by sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells. Blood 93 (1999) 4293-4299
40. Kwon Y.G., Min J.K., Kim K.M., Lee D.J., Billiar T.R., and Kim Y.M. Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J Biol Chem 276 (2001) 10627-10633
41. Kimura T., Sato K., Kuwabara A., et al. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J Biol Chem 276 (2001) 31780-31785
42. English D., Welch Z., Kovala A.T., et al. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J 14 (2000) 2255-2265
43. Panetti T.S., Nowlen J., and Mosher D.F. Sphingosine-1-phosphate and lysophosphatidic acid stimulate endothelial cell migration. Arterioscler Thromb Vasc Biol 20 (2000) 1013-1019
44. Liu F., Verin A.D., Wang P., et al. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity. Am J Respir Cell Mol Biol 24 (2001) 711-719
45. Paik J.H., Chae S., Lee M.J., Thaganda S., and Hla T. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J Biol Chem 276 (2001) 11830-11837
46. Gratzinger D., Canosa S., Engelhardt B., and Madri J.A. Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho. FASEB J 17 (2003) 1458-1469
47. Lee O.H., Kim Y.M., Lee Y.M., et al. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 264 (1999) 743-750
48. Wang F., Van Brocklyn J.R., Hobson J.P., et al. Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J Biol Chem 274 (1999) 35343-35350
49. Argraves K.M., Wilkerson B.A., Argraves W.S., Fleming P.A., Obeid L.M., and Drake C.J. Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. J Biol Chem 279 (2004) 50580-50590
50. Miura S., Tanigawa H., Matsuo Y., Fujino M., Kawamura A., and Saku K. Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells. Biochem Biophys Res Commun 306 (2003) 924-929
51. Rikitake Y., Hirata K., Kawashima S., et al. Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. Arterioscler Thromb Vasc Biol 22 (2002) 108-114
52. Li Y., Uruno T., Haudenschild C., Dudek S.M., Garcia J.G., and Zhan X. Interaction of cortactin and Arp2/3 complex is required for sphingosine-1-phosphate-induced endothelial cell remodeling. Exp Cell Res 298 (2004) 107-121
53. Igarashi J., and Michel T. Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J Biol Chem 275 (2000) 32363-32370
54. Igarashi J., Bernier S.G., and Michel T. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. Differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem 276 (2001) 12420-12426
55. Tanimoto T., Jin Z.G., and Berk B.C. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J Biol Chem 277 (2002) 42997-43001
56. Tolle M., Levkau B., Keul P., et al. Immunomodulator FTY720 induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ Res 96 (2005) 913-920
57. Kimura T., Tomura H., Mogi C., et al. Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells. Cell Signal 18 (2006) 841-850
58. Bolick D.T., Srinivasan S., Kim K.W., et al. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler Thromb Vasc Biol 25 (2005) 976-981
59. Whetzel A.M., Bolick D.T., Srinivasan S., et al. Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor. Circ Res 99 (2006) 731-739
60. Tamama K., Kon J., Sato K., et al. Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells. Biochem J 353 (2001) 139-146
61. Ryu Y., Takuwa N., Sugimoto N., et al. Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. Circ Res 90 (2002) 325-332
62. Kluk M.J., and Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim Biophys Acta 1582 (2002) 72-80
63. Tanimoto T., Lungu A.O., and Berk B.C. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. Circ Res 94 (2004) 1050-1058
64. Waters C., Sambi B., Kong K.C., et al. Sphingosine 1-phosphate and platelet-derived growth factor (PDGF) act via PDGF beta receptor-sphingosine 1-phosphate receptor complexes in airway smooth muscle cells. J Biol Chem 278 (2003) 6282-6290
65. Kluk M.J., Colmont C., Wu M.T., and Hla T. Platelet-derived growth factor (PDGF)-induced chemotaxis does not require the G protein-coupled receptor S1P1 in murine embryonic fibroblasts and vascular smooth muscle cells. FEBS Lett 533 (2003) 25-58
66. Okamoto H., Takuwa N., Yokomizo T., et al. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol 20 (2000) 9247-9261
67. Sugimoto N., Takuwa N., Okamoto H., Sakurada S., and Takuwa Y. Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 23 (2003) 1534-1545
68. Kawata T., Ishizuka T., Tomura H., et al. Sphingosine 1-phosphate inhibits migration and RANTES production in human bronchial smooth muscle cells. Biochem Biophys Res Commun 331 (2005) 640-647
69. Kimura T., Sato K., Malchinkhuu E., et al. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler Thromb Vasc Biol 23 (2003) 1283-1288
70. Tamama K., Tomura H., Sato K., et al. High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. Atherosclerosis 178 (2005) 19-23
71. Kimura T., Tomura H., Mogi C., et al. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J Biol Chem 281 (2006) 37457-37467
72. Damirin A., Tomura H., Komachi M., et al. Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol 292 (2007) H2513-H2522
73. Nofer J.R., Geigenmüller S., Göpfert C., Assmann G., Buddecke E., and Schmidt A. High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells. Biochem Biophys Res Commun 310 (2003) 98-103
74. Nofer J.R., Levkau B., Wolinska I., et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 276 (2001) 34480-34485
75. Matsuo Y., Miura S.I., Kawamura A., Uehara Y., Rye K.A., and Saku K. Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis 194 (2007) 159-168
76. Keul P., Tölle M., Lucke S., et al. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 27 (2007) 607-613
77. Nofer J.R., Bot M., Brodde M., et al. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 115 (2007) 501-508
78. Klingenberg R., Nofer J.R., Rudling M., et al. Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 27 (2007) 2392-2399
79. Swirski F.K., Libby P., Aikawa E., et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117 (2007) 195-205
80. Shimizu T., Nakazawa T., Cho A., et al. Sphingosine 1-phosphate receptor 2 negatively regulates neointimal formation in mouse arteries. Circ Res (2007) Sep 13; [Epub ahead of print]
81. Calabresi L., Rossoni G., Gomaraschi M., Sisto F., Berti F., and Franceschini G. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release. Circ Res 92 (2003) 330-337
82. Jin Z.Q., Zhou H.Z., Zhu P., et al. Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol 282 (2002) H1970-H1977
83. Theilmeier G., Schmidt C., Herrmann J., et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114 (2006) 1403-1409
84. Deutschman D.H., Carstens J.S., Klepper R.L., et al. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J 146 (2003) 62-68